33 Recruiting Studies Using Gemcitabine Hydrochloride
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Gemcitabine Hydrochloride
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
📍 City of Hope Corona — Corona, California
FIGO Stage IVA Ovarian Cancer
View Study & Checklist ➔Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage IB Lung Non-Small Cell Carcinoma AJCC v7
View Study & Checklist ➔Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Urothelial Carcinoma
View Study & Checklist ➔Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Metastatic Fallopian Tube Carcinoma
View Study & Checklist ➔Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Ovarian Serous Tumor
View Study & Checklist ➔Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Pancreatic Adenocarcinoma
View Study & Checklist ➔Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
📍 City of Hope Medical Center — Duarte, California
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Bladder Urothelial Carcinoma
View Study & Checklist ➔Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist ➔Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Ovarian Brenner Tumor
View Study & Checklist ➔A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
📍 Sutter Auburn Faith Hospital — Auburn, California
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
View Study & Checklist ➔Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Infiltrating Bladder Urothelial Carcinoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer
📍 Keck Medicine of USC Koreatown — Los Angeles, California
Lung Non-Small Cell Squamous Carcinoma
View Study & Checklist ➔Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Locally Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Metastatic Bladder Urothelial Carcinoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Bladder Flat Urothelial Carcinoma In Situ
View Study & Checklist ➔GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Adult Solid Neoplasm
View Study & Checklist ➔Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
EBV Infection
View Study & Checklist ➔Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Advanced Bile Duct Carcinoma
View Study & Checklist ➔Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage II Gallbladder Cancer AJCC v8
View Study & Checklist ➔Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Clear Cell Adenocarcinoma
View Study & Checklist ➔Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
📍 Mayo Clinic Health Systems-Mankato — Mankato, Minnesota
Clonal Cytopenia of Undetermined Significance
View Study & Checklist ➔Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Pancreatic Cystic Neoplasm
View Study & Checklist ➔Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
Locally Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Renal Pelvis and Ureter Urothelial Carcinoma
View Study & Checklist ➔CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
📍 Northwestern University — Chicago, Illinois
Advanced Biliary Tract Carcinoma
View Study & Checklist ➔Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔